MPO and inflammatory bowel disease: Another study in rats found that the HE β-glucan did improve inflammatory bowel disease (IBD)-induced colonic mucosa changes, because it promoted the growth of beneficial gut bacteria, which may have improved host immunity by reducing the activation of myeloperoxidase (MPO), nuclear factor kappa B (NFKB) and T cells [77].